Cargando…
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is a...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123055/ https://www.ncbi.nlm.nih.gov/pubmed/33923153 http://dx.doi.org/10.3390/cancers13092056 |
_version_ | 1783692792817516544 |
---|---|
author | Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. |
author_facet | Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. |
author_sort | Gasparri, Maria Luisa |
collection | PubMed |
description | SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is an experimental procedure to reduce lymphatic morbidity. The aim of our systematic review and meta-analysis is to investigate the effects of fibrin sealants on lymphatic morbidity after axillary dissection. Our results show that this experimental procedure is able to decrease the total axillary drainage output, the number of days before the axillary drainage is removed, and the length of hospital stay. However, no effects on the occurrence rate of axillary lymphocele or on the surgical site complications rate were demonstrated ABSTRACT: Background: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. Methods: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. Results: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin’s disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). Conclusion: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found. |
format | Online Article Text |
id | pubmed-8123055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81230552021-05-16 Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. Cancers (Basel) Systematic Review SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is an experimental procedure to reduce lymphatic morbidity. The aim of our systematic review and meta-analysis is to investigate the effects of fibrin sealants on lymphatic morbidity after axillary dissection. Our results show that this experimental procedure is able to decrease the total axillary drainage output, the number of days before the axillary drainage is removed, and the length of hospital stay. However, no effects on the occurrence rate of axillary lymphocele or on the surgical site complications rate were demonstrated ABSTRACT: Background: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. Methods: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. Results: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin’s disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). Conclusion: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found. MDPI 2021-04-24 /pmc/articles/PMC8123055/ /pubmed/33923153 http://dx.doi.org/10.3390/cancers13092056 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title | Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title_full | Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title_fullStr | Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title_full_unstemmed | Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title_short | Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
title_sort | fibrin sealants and axillary lymphatic morbidity: a systematic review and meta-analysis of 23 clinical randomized trials |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123055/ https://www.ncbi.nlm.nih.gov/pubmed/33923153 http://dx.doi.org/10.3390/cancers13092056 |
work_keys_str_mv | AT gasparrimarialuisa fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT kuehnthorsten fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT ruscitoilary fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT zuberveronica fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT dimiccorosa fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT galianoilaria fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT navarroquinonessiobanac fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT santurroletizia fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT divittoriofrancesca fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT meanifrancesco fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT bassivalerio fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT ditschnina fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT muellermichaeld fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT bellatifilippo fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT casertadonatella fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT papadiaandrea fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials AT gentiliniorested fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials |